By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...

By Puyaan Singh March 4 (Reuters) - Moderna shares rose 9% on Wednesday after it settled a long-running legal battle over the ...

TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...

Teva is undergoing a major business transition, but dividend investors should check out this 6.3% yielding competitor instead ...

Pfizer has launched its 2026 Apprenticeship Programme at Grange Castle, offering 22 apprenticeships in science, engineering, ...

One of the most powerful voices in the biopharma industry, Pfizer CEO Albert Bourla, Ph.D., has weighed in with sharp ...

Those were in great demand at the beginning of the pandemic, and generated gobs of money for Pfizer. Demand has waned, though ...

Oncology projects currently take up about 40% of Pfizer’s overall R&D budget. | After steering positive key pivotal readouts ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Best Dividend Stocks to Invest in Under $50. On March 2, Argus upgraded ...

Pfizer (PFE)-backed Priovant Therapeutics wins U.S. FDA's priority review for skin disorder therapy with a targeted action ...

A lawmaker compared getting the vaccine with using meth. The Idaho Medical Association said his bill would infringe on ...

S&P 500 concentration risk is surging—top 10 now 41%. See a quant-optimized 15-stock barbell from Strong Buy picks for better ...